|
Market Closed -
NYSE
16:00:02 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 48.13 USD | +0.02% |
|
-3.53% | -1.86% |
| 09-11 | GSK to shut vaccine factory in Germany, putting 641 jobs at risk | RE |
| 09-10 | GSK gets Japan approval for prefilled Shingrix vaccine | AN |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 31.77x | 20.16x | 0.6x | 11.54x | 23.41x | 24.8x | 0.62% | 994B | ||
| 29.54x | - | -1.6x | - | - | - | 2.02% | 640B | ||
| 32.92x | -468.23x | 0.14x | 7.63x | 15.78x | 16.44x | 2.67% | 454B | ||
| 18.71x | 6.85x | 1.27x | 4.57x | 11.31x | 12.54x | 2.91% | 337B | ||
| 19.41x | 5.51x | -10.47x | 5.08x | 12.59x | 13.42x | 3.21% | 261B | ||
| 20.34x | 4.55x | 1.07x | 4.19x | 11.96x | 12.58x | 2.11% | 246B | ||
| 23.87x | 18.03x | 2.15x | 6.3x | 11.23x | 14.47x | 2.67% | 204B | ||
| 12.3x | 5.22x | -5.06x | 4.48x | 9.37x | 10.92x | 4.08% | 190B | ||
| -43.47x | 10.7x | 0.29x | 6.35x | 24.81x | 60.02x | 2.29% | 178B | ||
| 17.48x | 1.8x | 1.05x | 3.3x | 8.45x | 9.61x | 6.21% | 158B | ||
| 52.98x | 8.36x | -1.45x | 9.54x | 32.7x | 26.25x | -.--% | 131B | ||
| 11.34x | 5.34x | 0.18x | 3.18x | 8.26x | 8.96x | 3.97% | 130B | ||
| 11.67x | 1.19x | -6.05x | 2.08x | 6.74x | 7.46x | 5.81% | 102B | ||
| 13.51x | 4.33x | -1.9x | 2.7x | 8x | 8.9x | 3.93% | 95.94B | ||
| 20.88x | 4.71x | 1.25x | 6.96x | 13.2x | 13.85x | 2.12% | 68.8B | ||
| 44.86x | 1.21x | 12.73x | 2.76x | 9.74x | 27.55x | 3.61% | 58.91B | ||
| 21.78x | 1.68x | -0.14x | 1.69x | 7.97x | 13.69x | 0.33% | 54.92B | ||
| 53.11x | 5.01x | -1.26x | 3.32x | 12.26x | 13.86x | -.--% | 43.22B | ||
| 30.65x | 4.14x | 1.7x | 7.08x | 24x | 26.84x | 0.57% | 41.9B | ||
| Average | 22.30x | -19.97x | -0.29x | 5.15x | 13.99x | 17.90x | 2.59% | 231B | |
| Weighted average by Cap. | 23.65x | -47.42x | -0.64x | 6.92x | 16.16x | 19.06x | 2.29% |
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
- Sector GSK plc
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















